Get the best of CNBC in your inbox
New technology funded by the Defense Advanced Research Projects Agency (DARPA) is helping change the way we think about prosthetics.
CNBC's Dominic Chu reports on Sarepta Therapeutics and its Duchenne muscular dystrophy drug trial. The "FMHR" traders weigh in on the trade.
The "FMHR" traders and JPMorgan's Dubravko Lakos-Bujas discuss the likelihood of a June rate hike from the Federal Reserve and what the market environment could look like.